|
Search
Collections
Benchmarks
Upload document
Product
methyl-aminolevulinate
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Basal Cell Carcinoma
Clinical trial
A Randomized, Observer Blind, Multinational Phase III Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) in Comparison to Metvix® in the Treatment of Non-aggressive Basal Cell Carcinoma (BCC) With Photodynamic Therapy (PDT)
Status: Completed
, Estimated PCD: 2015-11-17
